MedicinefromSilicon Valley Journals4 weeks agoAusperBio Raises $63 Million in Series B2 FinancingAusperBio closed a $63 million Series B2 to fund pivotal development of AHB-137, expand global trials, and advance the Med-Oligo™ ASO platform.
Public healthfromwww.mercurynews.com2 months agoHepatitis B, liver cancer a Bay Area health tragedy hidden in plain sight'Chronic hepatitis B disproportionately affects Asian Americans, with significant health risks and late diagnoses due to lack of awareness.